MTM Investment Management’s Aflac AFL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$530K Hold
4,522
0.15% 128
2026
Q1
$496K Hold
4,522
0.16% 126
2025
Q4
$499K Hold
4,522
0.16% 123
2025
Q3
$505K Sell
4,522
-28
-0.6% -$2.94K 0.16% 127
2025
Q2
$480K Buy
4,550
+227
+5% +$23.9K 0.16% 129
2025
Q1
$486K Hold
4,323
0.19% 124
2024
Q4
$447K Buy
4,323
+29
+0.7% +$3.16K 0.17% 124
2024
Q3
$495K Sell
4,294
-1,401
-25% -$142K 0.19% 117
2024
Q2
$509K Buy
5,695
+5
+0.1% +$430 0.21% 108
2024
Q1
$489K Buy
5,690
+34
+0.6% +$2.79K 0.2% 112
2023
Q4
$467K Buy
5,656
+5
+0.1% +$403 0.21% 108
2023
Q3
$434K Buy
5,651
+1,170
+26% +$86.9K 0.22% 104
2023
Q2
$313K Buy
4,481
+6
+0.1% +$402 0.15% 131
2023
Q1
$289K Buy
4,475
+6
+0.1% +$411 0.15% 139
2022
Q4
$322K Buy
4,469
+5
+0.1% +$335 0.17% 124
2022
Q3
$251K Buy
4,464
+6
+0.1% +$353 0.14% 147
2022
Q2
$251K Buy
4,458
+1,007
+29% +$59.4K 0.14% 149
2022
Q1
$222K Buy
3,451
+6
+0.2% +$376 0.11% 167
2021
Q4
$201K Buy
+3,445
New +$193K 0.1% 189
2021
Q3
Sell
-3,813
Closed -$205K 267
2021
Q2
$205K Buy
+3,813
New +$208K 0.11% 162

Other funds holding AFL

MTM Investment Management's AFL Position: Q2 2026 in Review

MTM Investment Management held its Aflac (AFL) position steady in Q2 2026 at 4,522 shares worth $530K. The position accounts for 0.15% of the portfolio, ranked #128.

MTM Investment Management first reported a position in AFL in Q2 2021 and has held it in 20 quarters since. 1,694 funds tracked by Wall St. Rank hold AFL as of Q2 2026.

  • MTM Investment Management held 4,522 shares of Aflac worth $530K as of Q2 2026.
  • MTM Investment Management left its Aflac share count unchanged in Q2 2026.
  • Aflac made up 0.15% of MTM Investment Management's portfolio in Q2 2026, its #128 holding.
  • MTM Investment Management first reported a position in Aflac in Q2 2021 and has held it in 20 quarters since.
  • 1,694 funds tracked by Wall St. Rank held Aflac as of Q2 2026.

Based on MTM Investment Management's 13F filing for Q2 2026, filed 3 Aug 2026.